QuidelOrtho Reports First Quarter 2026 Financial Results Accessibility Statement Skip Navigation LEX Diagnostics Acquisition Expected to Accelerate Growth in Point-of-Care Molecular Diagnostics Key Product Launches in U.S. and International Markets Expected to Drive Future Growth Company Updates Full- Year 2026 Financial Guidance SAN DIEGO, May 5, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of innovative in vitro diagnostics, today announced ...